Products with Antioxidants Bioactivity
Explore BioCrick products associated with Antioxidants biological activity, including catalog numbers, product names and available bioactivity information.
Antioxidants Bioactivity Products
| Cat. No. | Product Name |
|---|---|
| BCN1227 | Theobromine |
| Theobromine is a xanthine alkaloid widely consumed as stimulants and snacks in coffee and cocoa based foods, it may form the basis for a new class of antitussive drugs. Theobromine has antioxidants and also capable of prooxidant action, it may have therapeutic potential for diabetic nephropathy, by reducing kidney ECM accumulation in diabetic. It can inhibit adenosine receptor A1 (AR1) signaling. | |
| BCN1228 | (+)-Ulopterol |
| 1. (R)-peucedanol has radical scavenging on 1,1-diphenyl-2-picrylhydrazyl radical and for inhibition of oxidation of liposome induced by 2,2'-azobis(2-amidinopropane) dihydrochloride, it may have antioxidant activity. | |
| BCN1229 | L-Carnitine inner salt |
| L-carnitine is constituent of striated muscle and liver, it is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias. L-Carnitine inner salt regulates the PTEN/Akt/mTOR signaling pathway, and enhances axonal plasticity while concurrently ameliorating oxidative stress and increasing oligodendrocyte myelination of axons, thereby improving WMLs and cognitive impairment in a rat chronic hypoperfusion model. | |
| BCN1230 | Cyanidin-3-O-glucoside chloride |
| Cyanidin-3- O -glucoside exhibits strong antioxidant activities, it has protective effects from blackberry extract against peroxynitrite-induced endothelial dysfunction and vascular failure. Cyanidin-3-O-glucoside chloride decreased mutant p21 expression, and increased the ratio of Bax/Bcl-2 and the activation of caspase-3 to induce apoptosis. | |
| BCN1231 | Cyanidin Chloride |
| Cyanidin Chloride, the main phenolic antioxidant in the grape (Vitis vinifera), in particular in the liposomal forms, could be used for treatment of diabetes mellitus complications. It has a dual effect on RANKL-induced osteoclastogenesis, exhibits therapeutic potential in prevention of osteoclasts related bone disorders. | |


